Lysteda
NDC Package 55566-2100-2
Package Information
Lysteda is a medication used to treat heavy bleeding during your menstrual period. Marketed by Ferring Pharmaceuticals Inc., this product is identified by NDC 55566-2100 and is authorized under FDA application NDA022430.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55566 - Ferring Pharmaceuticals Inc.
- 55566-2100 - Lysteda
- 55566-2100-2 - 1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE
- 55566-2100 - Lysteda
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55566-2100). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55566-2100-2 identifies a specific commercial package of 1 bottle in 1 carton / 30 tablet in 1 bottle of Lysteda, labeled by Ferring Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ferring Pharmaceuticals Inc. on May 17, 2010. The current certification is valid through December 31, 2015.
What are the primary indications for this medication?
This medication is used to treat heavy bleeding during your menstrual period. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. It belongs to a class of drugs known as antifibrinolytics. Tranexamic acid is not a hormone. It does not treat other menstrual or pre-menstrual symptoms. It does not stop your period. It is not a form of birth control and does not protect against sexually transmitted diseases.
How is this Ferring Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55566210002. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.